The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): development, validity, reliability and sensitivity to change
- PMID: 22387055
- DOI: 10.1016/j.jad.2012.01.030
The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): development, validity, reliability and sensitivity to change
Abstract
Background: Some patients with major depression report a restricted range of emotions that may appear to arise as a side-effect of treatment with antidepressants. It is uncertain whether this phenomenon, sometimes called emotional blunting, represents residual symptoms of depression or side-effects of antidepressant treatment. There is currently no adequate instrument to measure this phenomenon.
Methods: A draft questionnaire was developed from patient-derived qualitative data, refined using cognitive interviewing, and administered on three occasions to patients taking antidepressants. Statistical methods including factor analysis were used to reduce the size of the draft questionnaire, and to assess the performance of the resulting Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA).
Results: 207 patients completed the OQuESA on at least one occasion. Their BDI-II scores and self-reported emotional blunting were spread across the possible range. The factor analysis resulted in four dimensions: 'not caring', 'emotional detachment', 'reduction in positive emotions', and 'general reduction in emotions'. The OQuESA appears to be acceptable, valid, and reliable, with sensitivity to change.
Conclusions: The OQuESA offers promise as an effective self-report measure of the symptoms of emotional blunting in patients with depression. It can be used as a clinical tool, to facilitate the identification of patients with the syndrome of emotional blunting. It should also be used in research studies, to advance our understanding of the nature, causes and treatment of this phenomenon.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Emotional blunting with antidepressant treatments: A survey among depressed patients.J Affect Disord. 2017 Oct 15;221:31-35. doi: 10.1016/j.jad.2017.05.048. Epub 2017 Jun 6. J Affect Disord. 2017. PMID: 28628765
-
Reliability and validity of the Chinese version of the Oxford Depression Questionnaire (ODQ-Chinese).J Affect Disord. 2022 Sep 15;313:278-282. doi: 10.1016/j.jad.2022.06.044. Epub 2022 Jun 30. J Affect Disord. 2022. PMID: 35779672
-
Symptom relief and facilitation of emotional processing.Eur Neuropsychopharmacol. 2011 Sep;21 Suppl 4:S710-5. doi: 10.1016/j.euroneuro.2011.07.016. Epub 2011 Aug 23. Eur Neuropsychopharmacol. 2011. PMID: 21865015 Review.
-
Evaluation of Emotional Adverse Effects of Antidepressants: A Follow-up Study.J Clin Psychopharmacol. 2020 Nov/Dec;40(6):594-598. doi: 10.1097/JCP.0000000000001300. J Clin Psychopharmacol. 2020. PMID: 33065720
-
Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?J Psychopharmacol. 2013 Aug;27(8):719-31. doi: 10.1177/0269881112474523. Epub 2013 Feb 7. J Psychopharmacol. 2013. PMID: 23392757 Review.
Cited by
-
Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder.Neuropsychiatr Dis Treat. 2025 Apr 12;21:841-854. doi: 10.2147/NDT.S485109. eCollection 2025. Neuropsychiatr Dis Treat. 2025. PMID: 40313313 Free PMC article.
-
Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib.Int J Neuropsychopharmacol. 2024 Mar 1;27(3):pyad066. doi: 10.1093/ijnp/pyad066. Int J Neuropsychopharmacol. 2024. PMID: 38441216 Free PMC article. Clinical Trial.
-
Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life.Ann Gen Psychiatry. 2022 Jun 20;21(1):20. doi: 10.1186/s12991-022-00392-4. Ann Gen Psychiatry. 2022. PMID: 35725552 Free PMC article.
-
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.Neuropsychiatr Dis Treat. 2023 Nov 8;19:2401-2412. doi: 10.2147/NDT.S428443. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38029050 Free PMC article.
-
Default mode and task-positive networks connectivity during the N-Back task in remitted depressed patients with or without emotional residual symptoms.Hum Brain Mapp. 2017 Jul;38(7):3491-3501. doi: 10.1002/hbm.23603. Epub 2017 Apr 8. Hum Brain Mapp. 2017. PMID: 28390165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical